
    
      This is an open-labeled exploratory study to evaluate safety and efficacy of FB825 in adults
      with atopic dermatitis (AD). The study will be conduct at one medical center in Taiwan.

      Approximately 12 subjects with atopic dermatitis (AD), who meet the criteria for study entry,
      will be enrolled to the one-arm-study.
    
  